Drug discovery process

Xem 1-14 trên 14 kết quả Drug discovery process
  • Natural products are a constant source of potentially active compounds for the treatment of various disorders. The Middle East and tropical regions are believed to have the richest supplies of natural products in the world. Plant derived secondary metabolites have been used by humans to treat acute infections, health disorders and chronic illness for tens of thousands of years. Only during the last 100 years have natural products been largely replaced by synthetic drugs.

    pdf524p phoebe75 19-02-2013 22 8   Download

  • The discovery of efficacious new human therapeutic agents is one of humanity’s most vital tasks. It is an enormously demanding activity that requires creativity, a vast range of scientific knowledge, and great persistence. It is also an exceedingly expensive activity. In an ideal world, no education would be complete without some exposure to the ways in which new medicines are discovered and developed. For those young people interested in science or medicine, such knowledge is arguably mandatory....

    pdf293p huutoan1990bk 12-09-2011 85 40   Download

  • Great efficiencies have been achieved in the drug discovery process as a result of technological advances in target identification, high-throughput screening, high-throughput organic synthesis, just-in-time in vitro ADME (absorption, distribution, metabolism, and excretion), and early pharmacokinetic screening of drug leads. These advances, spanning target selection all the way through to clinical candidate selection, have placed greater and greater demands on the analytical community to develop robust high-throughput methods.

    pdf41p bigbaby87 03-09-2010 60 17   Download

  • The modern drug discovery process, in general, involves the identification of a biochemical target (usually protein target), screening of synthetic compounds or compound libraries from combinatorial chemistry/natural sources for a lead compound, and optimization of the lead compound (activity, selectivity, pharmacokinetics, etc.) for recommending a potential clinical candidate.

    pdf63p bigbaby87 03-09-2010 66 13   Download

  • Despite massive efforts in drug discovery fueled by combinatory chemistry, recombinant DNA technology, and highthroughput screening, surprisingly few molecules make it through the drug development process. While the reasons are debated, it is certain that many new chemical entities (NCEs) suffer from recurring problems that hinder development— low water solubility, instability, or inadequate pharmacokinetics. An estimated 43% of NCEs are poorly water-soluble.

    pdf679p thuytienvang_1 31-10-2012 24 8   Download

  • In a certain sense, the field of drug metabolism (DM) is standing still. More specifically, the basic experiment of drug metabolism (i.e., administering a new drug to an animal or human and determining the structures, amounts, and disposition of the metabolites) has changed very little over a period of decades. Remarkably, the experimental design and resulting data set from a typical absorption, distribution, metabolism, and excretion (ADME) study conducted today would be instantly recognized and understood by DM scientists from 50 years ago.

    pdf785p thienbinh1311 13-12-2012 21 5   Download

  • Discovery of a new chemical entity that exerts pharmacological effects for curing or treating diseases or relieving symptoms is only the first step in the drug developmental process. In the developmental cycle of a new drug, the delivery of a desired amount of a therapeutic agent to the target at a specific time or duration is as important as its discovery. In order to realize the optimal therapeutic outcomes, a delivery system should be designed to achieve the optimal drug concentration at a predetermined rate and at the desired location....

    pdf0p echbuon 02-11-2012 22 2   Download

  • In the drug discovery area, a compound with desired therapeutic properties is identified, and its structure may be modified by synthetic alterations to enhance potency and specificity or to decrease toxicity and undesired side effects. The lead drug candidate is then transitioned into the drug development area. Only small amounts of drug (typically less than a gram) are required to support the required studies in the Drug Discovery area. However larger amounts are required to support the studies conducted in the Drug Development area.

    pdf37p bigbaby87 03-09-2010 49 7   Download

  • The urgent need to ensure the conservation of biological diversity is now widely recognised, but the role of an intellectual property rights regime as an instrument for biodiversity conservation is poorly understood and often hotly debated. This volume is a detailed analysis of the economic and scientific rationales for the use of a property rights-based approach to biodiversity conservation. It discusses the justification for, and implemen- tation of, intellectual property rights regimes as incentive systems to encourage conservation.

    pdf286p lyly_5 23-03-2013 20 6   Download

  • Addiction is a terrible thing. It consumes and controls us, makes us deny important truths and blinds us to the consequences of our actions. Our world is in the grip of a dangerous carbon habit. Coal and oil paved the way for the developed world’s industrial progress.

    pdf64p ranchoctdt7 16-07-2013 38 5   Download

  • Established in 2005 by the Association of Southeast Asian Nations (ASEAN) and with support from the European Union (EU), the ASEAN Centre for Biodiversity) ACB is regarded as the fi rst regional initiative to save the ASEAN region’s critically threatened biodiversity.

    pdf86p ranchoctdt7 16-07-2013 41 4   Download

  • The fight to stop biodiversity loss is at a critical moment. Species are currently going extinct at up to 1,000 times the natural background rate. Sixty per cent of examined ecosystem services worldwide have been degraded.

    pdf70p ranchoctdt7 16-07-2013 40 3   Download

  • This issue features some articles and reports about ASEAN Heritage Parks and other protected areas, their importance to the conservation and sustainable use of biodiversity resources of Southeast Asia (SEA), and the issues and threats that need to be addressed.

    pdf66p ranchoctdt7 16-07-2013 45 3   Download

  • Since biomarkers of safety and efficacy are becoming tools in drug development, it is necessary to determine whether these biomarkers can qualify for applications in clinical trials. Qualification is defined as “a conclusion that the biomarker data submitted support use of the biomarker in drug discovery, drug development or post approval studies and where appropriate, in regulatory decision making” (ICH E-16). A definition of validation was proposed during the workshop.

    pdf7p quynho77 14-11-2012 24 0   Download

CHỦ ĐỀ BẠN MUỐN TÌM

Đồng bộ tài khoản